Neurogene (NGNE) Goodwill & Intangibles (2019 - 2022)
Neurogene (NGNE) reported Goodwill & Intangibles of $18000.0 for Q2 2022, down 92.44% on a YoY basis from $238000.0 in Q2 2021, and down 75.34% quarter-over-quarter from $73000.0 in Q1 2022.
Neurogene (NGNE) Goodwill & Intangibles (2019 - 2022) Analysis & Trends
Neurogene has reported Goodwill & Intangibles for 4 years, with the latest figure at $18000.0 in Q2 2022.
- For the quarter ending Q2 2022, Goodwill & Intangibles fell 92.44% year-over-year to $18000.0; the trailing twelve-month figure through Jun 2022 stood at $18000.0 (down 92.44% YoY), and the FY2021 full-year result was $128000.0, down 63.11% from the prior year.
- Goodwill & Intangibles for Q2 2022 stood at $18000.0, down from $73000.0 in the prior quarter.
- The five-year high for Goodwill & Intangibles was $622000.0 in Q3 2019, with the low at $18000.0 in Q2 2022.
- Historically, Goodwill & Intangibles has averaged $320250.0 across 4 years, with a median of $320000.0 in 2020.
- Annual changes were most pronounced in 2020 — Goodwill & Intangibles tumbled 35.21% — and 2022, when it sank 92.44%.
- Neurogene's Goodwill & Intangibles stood at $567000.0 in 2019, then sank by 38.8% to $347000.0 in 2020, then tumbled by 63.11% to $128000.0 in 2021, then slumped by 85.94% to $18000.0 in 2022.
- The last three Goodwill & Intangibles figures came in at $18000.0 (Q2 2022), $73000.0 (Q1 2022), and $128000.0 (Q4 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Neurogene | 216.17 Mn | 216.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 18,000.00 |
| Mar 31, 2022 | 73,000.00 |
| Dec 31, 2021 | 128,000.00 |
| Sep 30, 2021 | 183,000.00 |
| Jun 30, 2021 | 238,000.00 |
| Mar 31, 2021 | 293,000.00 |
| Dec 31, 2020 | 347,000.00 |
| Sep 30, 2020 | 403,000.00 |
| Jun 30, 2020 | 458,000.00 |
| Mar 31, 2020 | 513,000.00 |
| Dec 31, 2019 | 567,000.00 |
| Sep 30, 2019 | 622,000.00 |